EVO EVO
Company Profile ↓Company Overview
EVO (EVO) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $788.37M (-1.1% YoY); net profit $-103.52M.
- Trailing 12 Months Year-on-year growth — revenue -1.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.61% |
| 1 Year: | -1.08% |
Stock Price Performance
| 1 Year: | -48.97% |
| 6 Months: | -47.76% |
| 3 Months: | -38.13% |
| 1 Month: | -30.53% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)33.32 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 52.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 199.98M | 171.24M | 163.89M | 253.27M | 156.64M |
| Cost of Revenue | - | 166.74M | 162.64M | 163.95M | 174.81M | 158.21M |
| Gross Profit | - | 33.24M | 8.59M | -62.00K | 78.46M | -1.57M |
| Operating Expenses | - | 53.05M | 37.19M | 44.55M | 41.26M | 44.85M |
| Operating Income | - | -19.82M | -28.60M | -44.61M | 37.21M | -46.42M |
| EBITDA | - | -27.44M | -37.42M | -40.68M | 33.22M | -119.60M |
| Interest Expense | - | 2.41M | 6.00M | 2.28M | 3.76M | 2.58M |
| Pretax Income | - | -29.85M | -43.42M | -42.96M | 29.46M | -122.18M |
| Tax Provision | - | 1.73M | 59.00K | 127.00K | 14.84M | -244.00K |
| Net Income | - | -31.58M | -43.48M | -43.09M | 14.62M | -121.94M |
| Diluted EPS | - | -0.09 | -0.12 | -0.12 | - | -0.34 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 751.45M | 781.43M | 796.97M | 788.37M |
| Cost of Revenue | - | 577.38M | 606.38M | 682.09M | 674.15M |
| Gross Profit | - | 174.06M | 175.05M | 114.88M | 114.22M |
| Operating Expenses | - | 153.22M | 201.68M | 193.80M | 170.04M |
| Operating Income | - | 20.85M | -26.63M | -78.92M | -55.82M |
| EBITDA | - | -57.61M | 24.12M | -80.66M | 27.15M |
| Interest Expense | - | 13.15M | 11.74M | 11.70M | 14.44M |
| Pretax Income | - | -153.96M | -80.59M | -193.98M | -86.77M |
| Tax Provision | - | 21.70M | 3.32M | 2.10M | 16.75M |
| Net Income | - | -175.66M | -83.91M | -196.08M | -103.52M |
| Diluted EPS | - | -0.49 | -0.23 | -0.56 | -0.29 |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 205.81M | 36.44M | 18.22M | -9.18M |
| Investing Cash Flow | - | -412.80M | -13.29M | -71.19M | 171.59M |
| Financing Cash Flow | - | -58.15M | 71.96M | -161.42M | -37.63M |
| Capital Expenditure | - | -181.35M | -216.00M | -132.24M | -82.62M |
| Free Cash Flow | - | 24.46M | -179.56M | -114.02M | -91.80M |
| Net Change in Cash | - | -265.13M | 95.11M | -214.39M | 124.78M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 23.2% | 22.4% | 14.4% | 14.5% |
| Operating Margin % | - | 2.8% | -3.4% | -9.9% | -7.1% |
| Net Margin % | - | -23.4% | -10.7% | -24.6% | -13.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for EVO
Evotec to Study NB4168 for Rare Pediatric Disease With No Approved Treatment - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNMUdiUnAxbWJ1OTVtQnRVVHRTTFZiWm83bnJxMWJDNV8wbVptbEprSGxQbS1IRVNXTXNJQjhVSEsyNWE3cFhxZ0ZjLWtZdXJkVE9XUnI2QmhwTy1OejcwQzU4a1MtUmlRYjFZN094NXZoVWgtWkU4SGtnVTg2WVlvbElYOENlOVlFYXhyYm…
Evotec SE (EVO) Stock Analysis: Unveiling Nearly 100% Upside Potential Amidst Strong Strategic Collaborations - DirectorsTalk Interviews
<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxOSjZBTDVkY1BNNnVmUzR3MEJJUlA1LW84MEozclBMQ1hpLV9scHVMVGc3RElsdTFsdTUtRHhIcmprUzZtWGF5RU44cnZpc2E2WGQ5X29Yak1wZ0JfamVsTzdaeTdNMnd3Q1J2OHI3Tmdsa3VCcXcxRmlxalFPSjdoQkEwcmI0NEpheTJCdH…
Evotec sees weak 2026 outlook after in-line 2025 results, $100 mln deal - Investing.com
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQbVpXdEhqMUpibTZLcUI3ZUtjeTNBTnpPYUUteWRXWXFWaXd4YUI1NWUwa01ZX3o3Nkc5S3h1NERtRlFncUJaSVlCV1NNWF8zUndCanZpdTVJalZLQ0VvUmhndWZEbld5eXpGYkxfQ1dKNEF4TlVwUG5oc0NNSmRhT19wNnlHSEJ0eWZTTG…
Acquisitions of own shares in Evolution AB (publ) - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNLThYdkZGSlNyV1J2cmNUbGtCZ0VqSWIxZTRzVS1jZmNiOUhMdEladV9HVEhGOHFCMVNNdTdVdkI0MmdKQXYxSWZERk9SRU1rTko2cjZqa2stZElscUw1N1lXR0JYVW5adlkxR3R6eHY5d29YQnpYSERuWFNVLVRPSjZmeWN5SklyM1RhWn…
Evolution (OM:EVO) Stock Faces Margin Decline That Challenges Bullish Growth Narratives - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxQbV9rOHd4a3pGd0VPdER2a3JMWE5kWGhRTzF5d2pXamhldU93b2VsZDljck9wVTR2NWNQazdWc1FQdWZDX3ZTVlBOTEdmWS1NQTQ2eE5NR2p0OTl4NFVTdUF4cW1BTWN3NFplWUszajljcF8ycHRQMS1xT01rZkM5UmhfWGtodTRMUnJGeF…
Key facts: Candle Lake Raises EVO Stake to 30.02%; Evolution Adds 1.02M - TradingView
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPZV9EUGRMMUFzYldpYVd5eGJsTXNJazVSTWZrU2dmTWw5dHVRTHVZeGFoUk5ud3ZVdFFWSUJVVjU3X1hnNjlkUHgzZjItTk1wYmxnekdPLWUtbEZHbnZxczRUZkxobGE4MnhUMjVkUDNNSUp6Z0dGRWp4NVU2dXdkazZiLURvMTBnYVZxRE…
EVO — Frequently Asked Questions
What is the current share price of EVO?
As of 2026-08-05 17:25 PDT, EVO trades at $1.98 on NASDAQ/NYSE. Its 52-week range is $1.91 to $4.15.
What is the P/E ratio of EVO?
EVO trades at a trailing price-to-earnings (P/E) ratio of -6.83.
Is EVO a good stock to buy?
This page provides a data-driven analysis of EVO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.